Adjuvant Chemotherapy After Lobectomy For T1-2N0 Non-Small Cell Lung Cancer: Are the Guidelines Supported?

BACKGROUND: Evidence guiding adjuvant chemotherapy (AC) use following lobectomy for stage I NSCLC is limited. This study evaluated the impact of AC use and tumor size on outcomes using a large, nationwide cancer database. METHODS: The effect of AC on long-term survival among patients who underwent l...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Natl Compr Canc Netw
Main Authors: Speicher, Paul J, Gu, Lin, Wang, Xiaofei, Hartwig, Matthew G, D’Amico, Thomas A, Berry, Mark F
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4779177/
https://ncbi.nlm.nih.gov/pubmed/26085391
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares